Circulars
-
2023 Delisting
- TRP Ruling Inspector's Report Consent Letter - Ascendis Health 19.03.2024 Consent Letter Ascendis_19.03.2024_BDO Solaris Consent Letter 19 March 2024 Valeo Capital Consent Letter 19 March 2024 (signed) APPROVAL - Ascendis Health Limited - Supplementary circular 22 Mar 2024 JOB028103 ASCENDIS Supplementary Circular Web (Final) Management Agreement Ascendis Delisting Circular (Signed Version) Ascendis Delisting Circular 1.1 Ascendis - Irrevocable Undertaking - Alpvest signed 2.1 Ascendis - Irrevocable Undertaking - KHI - signed 3.1 Ascendis - Irrevocable Undertaking - Option 4 - Remain Invested Only - Carl 5.1 Ascendis - Irrevocable Undertaking Steyn signed 6.1 Ascendis - Irrevocable Undertaking - Option 4 - Remain Invested Only - Blee 7.1.1 Aboobaker Signed IU 7.1.2 Aboobaker Signed IU 8.1 Ascendis - Irrevocable Undertaking PLN signed 9.1 Ascendis - Irrevocable Undertaking - Option 4 - Remain Invested Only - ACN 10.1 Ascendis - Irrevocable Undertaking (002) - Calibre 11.1 Cresthold IU 12.1 Ascendis - Irrevocable Undertaking - Marble Rock 28.1.2 Firm Intention Offer Letter 28.1.5 TRP Approval 28.1.6 Independent Expert Opinion Computershare Consent Letter ASC 11.12 Consent Letter Ascendis_11.12.2023_BDO Solaris Consent Letter 11 Dec 2023 - Signed Valeo Capital Consent Letter 11 Dec 2023 Ortho-Xact MOI Surgical Innovations MOI
-
2022 Pharma Disposal
- Ascendis Pharma Final HFIs Ascendis Pharma Interim HFIs Updated pro forma financial information in respect of the disposal of Ascendis Pharma Ascendis Circular Pharma Disposal
-
2021 Group Recapitalisation
- Animal Health Business Units - 30 June 2020 (29.08.2021) Animal Health Business Units-31 December 2020 (29.08.2021) Ascendis Health Europe Business Units - Interim(29.08.2021) Ascendis Health Europe Holdings (Luxembourg) - 30 June 2020 (29.08.2021) Respiratory Care Africa - 30 June 2020 (27.08.2021) Respiratory Care Africa - 31 December 2020 (27.08.2021) Ascendis Health Recapitalisation Circular
-
2017 Rights Offer
- Rights Offer of R750m Circular Notice to the fifth Annual General Meeting – held 09 November 2017